Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, L. L. C., Welsh and McKean Rds., Spring House, PA 19477, United States
Abstract:
A series of guanidine triazinediones were identified as potent PK1 receptor antagonists. A compound in this series inhibited the PK1 invoked prosecretory response in rat ileum tissue.